End
1 :

1100:

Client reports muscle weakness and tingling in their hands and face. Client is alert to person, place, time, and situation. Speech clear. Heart rate irregular. Radial pulse +3 bilateral. Respirations even and nonlabored. Scattered rhonchi posterior bases. Abdomen rounded and nondistended. Bowel sounds hyperactive in all 4 quadrants. Skin warm dry and intact. Capillary refill less than 2 seconds. Turgor elastic. No edema present.

1115: 

A Labs, vital signs, and ECG were obtained. Urinalysis collection is pending. Client is being transferred to the medical-surgical unit.

1100:

Temperature 36.4° C (97.5° F)

Heart rate 58/min

Respiratory rate 20/min

Blood pressure 98/64 mm Hg

Oxygen saturation 97% on room air

1115:

Temperature 36.4° C (97.5° F)

Heart rate 64/min

Respiratory rate 22/min

Blood pressure 104/70mm Hg

Oxygen saturation 96% on room air

1130:

Sodium 140 mEq/L (136 to 145 mEq/L)

Potassium 6 mEq/L (3.5 to 5 mEq/L)

BUN 18 mg/dL (10 to 20 mg/dL)

Creatinine 0.8 mg/dL (0.5 to 1 mg/dL)

Hgb 14 g/dL (12 to 16 g/dL)

Hct 45% (37% to 47%)

1130:

ECG: Peaked T waves with absent P waves. Rate is 58/min.


For each potential provider prescription, click to specify if the prescription is appropriate or inappropriate for the client. There must be at least 1 selection in every row. There does not need to be a selection in every column.


Provider Prescription appropriate inappropriate
Administer hydralazine IV.
Administer sodium polystyrene rectally.
Administer insulin IV.
Administer calcium gluconate IV.
Administer potassium chloride IV.

Hint : 🔶Stabilize the heart, then lower potassium.

Correct Answers

  • Administer hydralazine IV. [ inappropriate ]
  • Administer sodium polystyrene rectally. [ appropriate ]
  • Administer insulin IV. [ appropriate ]
  • Administer calcium gluconate IV. [ appropriate ]
  • Administer potassium chloride IV. [ inappropriate ]

Rationale :

Appropriate

Administer sodium polystyrene rectally

🔶Sodium polystyrene sulfonate lowers serum potassium by exchanging sodium for potassium within the gastrointestinal tract.

🔶The bound potassium is then removed from the body through stool, producing an actual reduction in total-body potassium.

🔶Rectal administration can be used when oral administration is not appropriate or when the client cannot safely take the medication by mouth.

🔶Its effect is relatively slow, so it should not be relied upon as the only treatment when hyperkalemia has already produced ECG abnormalities.

🔶It is appropriate as an adjunct to faster therapies while the nurse monitors bowel function, potassium levels, and signs of intestinal complications.

Administer insulin IV

🔶 Intravenous regular insulin rapidly shifts potassium from the extracellular fluid into the body’s cells.

🔶Insulin stimulates the sodium-potassium pump, lowering the serum potassium concentration without immediately removing potassium from the body.

🔶This intervention is appropriate because the client has both an elevated potassium level and dangerous ECG manifestations.

🔶IV dextrose is commonly administered with insulin unless the client is significantly hyperglycemic, because insulin can cause severe hypoglycemia.

🔶The nurse should monitor blood glucose frequently and reassess the potassium level and cardiac rhythm after treatment.

Administer calcium gluconate IV

🔶Intravenous calcium gluconate stabilizes the cardiac cell membrane and reduces the risk of ventricular dysrhythmias caused by hyperkalemia.

🔶It is especially indicated when ECG changes such as peaked T waves, absent P waves, bradycardia, or QRS widening are present.

🔶Calcium gluconate acts rapidly but does not lower the serum potassium concentration or remove potassium from the body.

🔶Potassium-lowering treatments such as insulin with dextrose must therefore be administered in addition to calcium.

🔶The nurse should maintain continuous ECG monitoring and administer the medication slowly through a patent IV line according to the prescribed rate.

Inappropriate

Administer hydralazine IV

🔶 Hydralazine is an antihypertensive vasodilator that lowers blood pressure and does not treat hyperkalemia or its cardiac effects.

🔶The client’s blood pressure is already low-normal at 98/64 mm Hg, so hydralazine could cause dangerous hypotension.

Administer potassium chloride IV

🔶Potassium chloride would further increase the client’s already elevated serum potassium and worsen the risk of lethal cardiac dysrhythmias.

🔶Potassium-containing medications and fluids should be withheld while emergency measures are used to stabilize the heart and reduce potassium.


Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

QLexNursing Calculator Click & Drag ×
AC
(
)
CE
π
e
φ
τ
Inv
sin-1
cos-1
tan-1
log
ln
!
deg
√
x²
x³
^
7
8
9
÷
4
5
6
×
1
2
3
-
0
.
exp
+
Rnd
Ans
=